HIV, the virus that causes AIDS, is shown budding out of an immune cell, which the virus infects and uses to replicate.NIH, via Wikimedia Commons
For more than 20 years, powerful drug combinations of antiretroviral drugs have been available to treat people with HIV infection, and these agents have dramatically raised life expectancy for HIV-infected patients from 36 to 49 years of age.
Though combinatorial antiretroviral therapies (CART) reduces viral
loads to undetectable levels in the blood, HIV can hide within the
central nervous system, where it can integrate into the genomes of brain
cells called microglia – the immune cells of the brain.
In the brain, HIV continues to produce viral proteins and damage both
infected and non-infected cells in the brain, boosting the risk for
dementia, addiction and other neurological problems. Everyone with HIV
will experience this, since HIV integrates into the genome and CART has
issues crossing into the brain. The question is: why?
HIV proteins dysregulate dopamine signaling
To answer this, we used a mouse in which we can control the levels of
HIV viral protein in order to probe the link between HIV infection and
neurological disease.
Our lab discovered that an HIV protein, called HIV-1 Tat, reduces the
level of an important protein required for the production of a
dopamine, a neurotransmitter, in the brain.
Dopamine is produced by neurons in the central nervous system and by immune cells in the blood. Using a confocal microscope
to see fine details, my colleagues and I carefully examined the
dopamine producing areas in the brains of mice containing HIV-1 Tat
protein and were surprised to discover that the neurons were alive. But,
many that normally produced dopamine were unable to produce as much. We
also found that an enzyme necessary to make dopamine, called tyrosine
hydroxylase, was no longer detectable in some neurons. This suggests
that the mice can’t make as much dopamine.
When microglial cells secrete the HIV-1 Tat protein, it is able to
enter dopamine neurons and lower their activity so that they produce
less dopamine. That reduces their ability to communicate with other
cells in the brain, which can disrupt the ability to move and reward
related behaviors. Also, low levels of dopamine in an area of the brain
called the substantia nigra is a hallmark of Parkinson’s and
predisposes patients to depression and addiction to drugs like methamphetamine and cocaine.
The results of our research, published in the journal Glia,
reveal how HIV patients are more vulnerable to neurological and
neuropsychiatric conditions that are somehow tied to disrupting dopamine
levels in the brain.
There is clearly more to treating HIV that curbing levels of the
virus in the blood. The medical community needs treatments that reverse
the long-term consequences of HIV infection in the brain.
The unique composition of a mother’s breastmilk may help to reduce food sensitization in her infant, report researchers at the University of California San Diego School of Medicine with colleagues in Canada. The findings, publishing in the June 15 issue of Allergy , further highlight the health role of human milk oligosaccharides (HMOs), which are not found in infant formula, and underscore their potential for therapeutic interventions. HMOs are structurally complicated sugar molecules unique to human breast milk. They are the third most abundant solid component in human milk after lactose (a different type of sugar) and fat. They are not actually digestible by infants, but act as a prebiotic, helping to guide development of the infant gut microbiota, which previous research suggests is a key influencer of allergic disease. Past research has shown that breastfed infants have a lower risk for a variety of medical conditions, such as wheezing, infections, asthma and ob...
Even living cells have their own tangled problems to solve. They involve knots that arise accidentally in DNA and that can comprise its functionality. A new study by SISSA (Scuola Internazionale Superiore di Studi Avanzati) brings a new twist to the problem and suggests that the DNA propensity to be supercoiled, just like telephone cords, can come to the rescue. These coils can keep DNA knots locked in place for long enough that they can be untied by specialised enzymes. The computational study, based on molecular dynamics simulations of bacterial DNA, has just been published in Nucleic Acids Research . A tangled problem Supercoiled, twisted, and even knotted! Far from the elegant and polished textbook images, DNA filaments in living cells is all crumpled and entangled and, to be functional, needs to be constantly unravelled, much like our telephone cords that with careless use accumulate annoying curls or supercoils. "Supercoils are, in fact, present in DNA too ...
Many of society’s energy challenges require gigawatts of power , but many more are small – and some are entirely microscopic. To drive a new generation of tiny micromachines that could deliver drugs or clean traces of pollution , physicists are increasingly looking to biology for inspiration. In work published in the journal Science Advances , my co-authors and I present a simulation of a sort of tiny “windfarm” powered by the natural self-organisation of bacteria. It’s a small step towards harnessing the energy potential of microorganisms. Active fluid-powered windfarms We used computer simulations to model many swimming bacteria, such as the E. coli you find in your gut. A dense crowd of these swimming bacteria isn’t too different from traditional, passive liquid, though there’s one major exception: it spontaneously flows, with internal whirling currents. Physicists have started calling anything that spontaneously flows in this way an “ active fluid ”. It looks som...
Comments
Post a Comment